Artemis Growth Partners Appoints James Hayward as Advisory Director
Artemis Growth Partners, an investment firm focused on regulated medical cannabis and emergent medicinal therapeutics, has appointed James Hayward as its new Advisory Director. With a 35-year career at JPMorgan, where he played a key role in developing the European credit distribution franchise, Hayward brings extensive experience across leveraged finance, high yield, and distressed markets to Artemis. His appointment aligns with the firm's strategy amid evolving regulatory frameworks and increasing institutional interest in medical cannabis. As the sector matures, Artemis is emphasizing governance, capital discipline, and sustainable business models. Co-founder William Muecke highlighted Hayward’s expertise as critical for navigating complex financing needs within a rapidly developing industry. Hayward expressed optimism about the potential of the medical cannabis market despite lingering stigma. He emphasized that most institutional investors are unaware of how quickly the sector is advancing. Artemis, managing over $300 million in assets across six investment vehicles globally, aims to leverage Hayward’s experience and credibility to deepen its engagement with hedge funds, private equity firms, and family offices.
Tickers: $JPM
Topics: Investment Firms Leadership Changes Medical Cannabis